Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytin
- 31 May 1996
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 23 (4) , 459-466
- https://doi.org/10.1016/0969-8051(96)00022-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49Nuclear Medicine and Biology, 1995
- Phase II radioimmunotherapy trial with131I-CC49 in colorectal cancerCancer, 1994
- A simple method to determine the immunoreactivity of radiolabelled monoclonal antibodies to the TAG-72 antigenApplied Radiation and Isotopes, 1993
- Specific recognition of antibody-oligonucleotide conjugates by radiolabeled antisense nucleotides: a novel approach for two-step radioimmunotherapy of cancerBioconjugate Chemistry, 1993
- Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidinEuropean Journal of Nuclear Medicine and Molecular Imaging, 1992
- Monoclonal antibody pretargetting techniques for tumour localizationNuclear Medicine Communications, 1991
- Effect of unlabelled monoclonal antibody (MoAb) on biodistribution of 111Indium labelled (MoAb)Nuclear Medicine Communications, 1988
- Monoclonal Antibody B72.3 Reacts with a Core Region Structure of O-Linked CarbohydratesTumor Biology, 1988
- Radioimmunoimaging with 99mTc monoclonal antibodies: Clinical studiesInternational Journal of Nuclear Medicine and Biology, 1984
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984